{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T11:16:44Z","timestamp":1792149404086,"version":"4.4.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T00:00:00Z","timestamp":1652486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T00:00:00Z","timestamp":1652486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Dyslipidemia is considered an essential component of the pathological process of amyotrophic lateral sclerosis (ALS), a fatal motor neuron disease. Although TAR DNA Binding Protein 43\u00a0kDa (TDP-43) links both familial and sporadic forms of ALS and cytoplasmic aggregates are a hallmark of most cases of ALS, the molecular mechanism and the in vivo relation of ALS dyslipidemia with TDP-43 have been unclear. To analyze the dyslipidemia-related gene expression by TDP-43, we performed expression microarray and RNA deep sequencing (RNA-Seq) using cell lines expressing high levels of TDP-43 and identified 434 significantly altered genes including sterol regulatory element-binding protein 2 (SREBP2), a master regulator of cholesterol homeostasis and its downstream genes. Elevated TDP-43 impaired SREBP2 transcriptional activity, leading to inhibition of cholesterol biosynthesis. The amount of cholesterol was significantly decreased in the spinal cords of TDP-43-overexpressed ALS model mice and in the cerebrospinal fluids of ALS patients. These results suggested that TDP-43 could play an essential role in cholesterol biosynthesis in relation to ALS dyslipidemia.<\/jats:p>","DOI":"10.1038\/s41598-022-12133-4","type":"journal-article","created":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T06:16:06Z","timestamp":1652508966000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["TDP-43 regulates cholesterol biosynthesis by inhibiting sterol regulatory element-binding protein 2"],"prefix":"10.1038","volume":"12","author":[{"given":"Naohiro","family":"Egawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuishin","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidefumi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itaru","family":"Tsuge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Shimano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Izumikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayoko","family":"Tsukita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Enami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoko","family":"Naitoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigehiko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuneyoshi","family":"Seki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsushi","family":"Toda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuji","family":"Kaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhisa","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,14]]},"reference":[{"key":"12133_CR1","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1146\/annurev.neuro.27.070203.144244","volume":"27","author":"LI Bruijn","year":"2004","unstructured":"Bruijn, L. I., Miller, T. M. & Cleveland, D. W. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 27, 723\u2013749. https:\/\/doi.org\/10.1146\/annurev.neuro.27.070203.144244 (2004).","journal-title":"Annu. Rev. Neurosci."},{"key":"12133_CR2","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann, M. et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130\u2013133. https:\/\/doi.org\/10.1126\/science.1134108 (2006).","journal-title":"Science"},{"key":"12133_CR3","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","volume":"351","author":"T Arai","year":"2006","unstructured":"Arai, T. et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351, 602\u2013611. https:\/\/doi.org\/10.1016\/j.bbrc.2006.10.093 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"12133_CR4","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1212\/WNL.0b013e3182840689","volume":"80","author":"V Gallo","year":"2013","unstructured":"Gallo, V. et al. Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: the EPIC cohort. Neurology 80, 829\u2013838. https:\/\/doi.org\/10.1212\/WNL.0b013e3182840689 (2013).","journal-title":"Neurology"},{"key":"12133_CR5","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1001\/jamaneurol.2015.1584","volume":"72","author":"MH Huisman","year":"2015","unstructured":"Huisman, M. H. et al. Effect of presymptomatic body mass index and consumption of fat and alcohol on amyotrophic lateral sclerosis. JAMA Neurol. 72, 1155\u20131162. https:\/\/doi.org\/10.1001\/jamaneurol.2015.1584 (2015).","journal-title":"JAMA Neurol."},{"key":"12133_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13024-018-0294-0","volume":"13","author":"A Jawaid","year":"2018","unstructured":"Jawaid, A., Khan, R., Polymenidou, M. & Schulz, P. E. Disease-modifying effects of metabolic perturbations in ALS\/FTLD. Mol. Neurodegener. 13, 63. https:\/\/doi.org\/10.1186\/s13024-018-0294-0 (2018).","journal-title":"Mol. Neurodegener."},{"key":"12133_CR7","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/ana.24936","volume":"81","author":"D Mariosa","year":"2017","unstructured":"Mariosa, D. et al. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort. Ann. Neurol. 81, 718\u2013728. https:\/\/doi.org\/10.1002\/ana.24936 (2017).","journal-title":"Ann. Neurol."},{"key":"12133_CR8","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00415-010-5805-z","volume":"258","author":"J Dorst","year":"2011","unstructured":"Dorst, J. et al. Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis. J. Neurol. 258, 613\u2013617. https:\/\/doi.org\/10.1007\/s00415-010-5805-z (2011).","journal-title":"J. Neurol."},{"key":"12133_CR9","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1212\/01.wnl.0000285080.70324.27","volume":"70","author":"L Dupuis","year":"2008","unstructured":"Dupuis, L. et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology 70, 1004\u20131009. https:\/\/doi.org\/10.1212\/01.wnl.0000285080.70324.27 (2008).","journal-title":"Neurology"},{"key":"12133_CR10","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1212\/WNL.0b013e3181c1df1e","volume":"73","author":"A Chio","year":"2009","unstructured":"Chio, A. et al. Lower serum lipid levels are related to respiratory impairment in patients with ALS. Neurology 73, 1681\u20131685. https:\/\/doi.org\/10.1212\/WNL.0b013e3181c1df1e (2009).","journal-title":"Neurology"},{"key":"12133_CR11","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/ana.25671","volume":"87","author":"L Zhang","year":"2020","unstructured":"Zhang, L., Tang, L., Huang, T. & Fan, D. Life course adiposity and amyotrophic lateral sclerosis: A Mendelian randomization study. Ann. Neurol. 87, 434\u2013441. https:\/\/doi.org\/10.1002\/ana.25671 (2020).","journal-title":"Ann. Neurol."},{"key":"12133_CR12","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1194\/jlr.M700017-JLR200","volume":"48","author":"A Fergani","year":"2007","unstructured":"Fergani, A. et al. Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis. J. Lipid Res. 48, 1571\u20131580. https:\/\/doi.org\/10.1194\/jlr.M700017-JLR200 (2007).","journal-title":"J. Lipid Res."},{"key":"12133_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017985","volume":"6","author":"SM Kim","year":"2011","unstructured":"Kim, S. M. et al. Amyotrophic lateral sclerosis is associated with hypolipidemia at the presymptomatic stage in mice. PLoS ONE 6, e17985. https:\/\/doi.org\/10.1371\/journal.pone.0017985 (2011).","journal-title":"PLoS ONE"},{"key":"12133_CR14","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.45114","author":"E Manzo","year":"2019","unstructured":"Manzo, E. et al. Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS. Elife https:\/\/doi.org\/10.7554\/eLife.45114 (2019).","journal-title":"Elife"},{"key":"12133_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fneur.2016.00047","volume":"7","author":"SK Hollinger","year":"2016","unstructured":"Hollinger, S. K., Okosun, I. S. & Mitchell, C. S. Antecedent disease and amyotrophic lateral sclerosis: What is protecting whom?. Front. Neurol. 7, 47. https:\/\/doi.org\/10.3389\/fneur.2016.00047 (2016).","journal-title":"Front. Neurol."},{"key":"12133_CR16","doi-asserted-by":"publisher","first-page":"9932","DOI":"10.1523\/JNEUROSCI.3355-05.2005","volume":"25","author":"M Valenza","year":"2005","unstructured":"Valenza, M. et al. Dysfunction of the cholesterol biosynthetic pathway in Huntington\u2019s disease. J. Neurosci. 25, 9932\u20139939. https:\/\/doi.org\/10.1523\/JNEUROSCI.3355-05.2005 (2005).","journal-title":"J. Neurosci."},{"key":"12133_CR17","doi-asserted-by":"publisher","first-page":"eabj0264","DOI":"10.1126\/scitranslmed.abj0264","volume":"14","author":"PJ Hop","year":"2022","unstructured":"Hop, P. J. et al. Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS. Sci. Transl. Med. 14, eabj0264. https:\/\/doi.org\/10.1126\/scitranslmed.abj0264 (2022).","journal-title":"Sci. Transl. Med."},{"key":"12133_CR18","doi-asserted-by":"publisher","first-page":"145ra104","DOI":"10.1126\/scitranslmed.3004052","volume":"4","author":"N Egawa","year":"2012","unstructured":"Egawa, N. et al. Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci. Transl. Med. 4, 145ra104. https:\/\/doi.org\/10.1126\/scitranslmed.3004052 (2012).","journal-title":"Sci. Transl. Med."},{"key":"12133_CR19","doi-asserted-by":"publisher","first-page":"7709","DOI":"10.1038\/s41598-017-06953-y","volume":"7","author":"K Izumikawa","year":"2017","unstructured":"Izumikawa, K. et al. TDP-43 stabilises the processing intermediates of mitochondrial transcripts. Sci. Rep. 7, 7709. https:\/\/doi.org\/10.1038\/s41598-017-06953-y (2017).","journal-title":"Sci. Rep."},{"key":"12133_CR20","doi-asserted-by":"publisher","first-page":"18809","DOI":"10.1073\/pnas.0908767106","volume":"106","author":"I Wegorzewska","year":"2009","unstructured":"Wegorzewska, I., Bell, S., Cairns, N. J., Miller, T. M. & Baloh, R. H. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc. Natl. Acad. Sci. USA. 106, 18809\u201318814. https:\/\/doi.org\/10.1073\/pnas.0908767106 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"12133_CR21","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","volume":"226","author":"J Folch","year":"1957","unstructured":"Folch, J., Lees, M. & Sloane Stanley, G. H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497\u2013509 (1957).","journal-title":"J. Biol. Chem."},{"key":"12133_CR22","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1002\/hep.21874","volume":"46","author":"N Matsuzawa","year":"2007","unstructured":"Matsuzawa, N. et al. Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. Hepatology 46, 1392\u20131403. https:\/\/doi.org\/10.1002\/hep.21874 (2007).","journal-title":"Hepatology"},{"key":"12133_CR23","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0092-8674(00)80213-5","volume":"89","author":"MS Brown","year":"1997","unstructured":"Brown, M. S. & Goldstein, J. L. The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89, 331\u2013340 (1997).","journal-title":"Cell"},{"key":"12133_CR24","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/nrendo.2017.91","volume":"13","author":"H Shimano","year":"2017","unstructured":"Shimano, H. & Sato, R. SREBP-regulated lipid metabolism: Convergent physiology-divergent pathophysiology. Nat. Rev. Endocrinol. 13, 710\u2013730. https:\/\/doi.org\/10.1038\/nrendo.2017.91 (2017).","journal-title":"Nat. Rev. Endocrinol."},{"key":"12133_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.brainres.2013.10.013","volume":"1584","author":"T Hatzipetros","year":"2014","unstructured":"Hatzipetros, T. et al. C57BL\/6J congenic Prp-TDP43A315T mice develop progressive neurodegeneration in the myenteric plexus of the colon without exhibiting key features of ALS. Brain Res. 1584, 59\u201372. https:\/\/doi.org\/10.1016\/j.brainres.2013.10.013 (2014).","journal-title":"Brain Res."},{"key":"12133_CR26","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/j.bbalip.2015.02.010","volume":"1083\u20131094","author":"G Saher","year":"1851","unstructured":"Saher, G. & Stumpf, S. K. Cholesterol in myelin biogenesis and hypomyelinating disorders. Biochim. Biophys. Acta 1083\u20131094, 2015. https:\/\/doi.org\/10.1016\/j.bbalip.2015.02.010 (1851).","journal-title":"Biochim. Biophys. Acta"},{"key":"12133_CR27","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201910213","author":"WY Ho","year":"2021","unstructured":"Ho, W. Y. et al. TDP-43 mediates SREBF2-regulated gene expression required for oligodendrocyte myelination. J. Cell Biol. https:\/\/doi.org\/10.1083\/jcb.201910213 (2021).","journal-title":"J. Cell Biol."},{"key":"12133_CR28","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1038\/nn.3230","volume":"15","author":"C Lagier-Tourenne","year":"2012","unstructured":"Lagier-Tourenne, C. et al. Divergent roles of ALS-linked proteins FUS\/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat. Neurosci. 15, 1488\u20131497. https:\/\/doi.org\/10.1038\/nn.3230 (2012).","journal-title":"Nat. Neurosci."},{"key":"12133_CR29","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1084\/jem.20111313","volume":"208","author":"V Swarup","year":"2011","unstructured":"Swarup, V. et al. Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor kappaB-mediated pathogenic pathways. J. Exp. Med. 208, 2429\u20132447. https:\/\/doi.org\/10.1084\/jem.20111313 (2011).","journal-title":"J. Exp. Med."},{"key":"12133_CR30","doi-asserted-by":"publisher","first-page":"9137","DOI":"10.1523\/JNEUROSCI.1388-20.2020","volume":"40","author":"JC Dodge","year":"2020","unstructured":"Dodge, J. C. et al. Neutral lipid cacostasis contributes to disease pathogenesis in amyotrophic lateral sclerosis. J. Neurosci. 40, 9137\u20139147. https:\/\/doi.org\/10.1523\/JNEUROSCI.1388-20.2020 (2020).","journal-title":"J. Neurosci."},{"key":"12133_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105289","volume":"152","author":"J Canet-Pons","year":"2021","unstructured":"Canet-Pons, J. et al. Atxn2-CAG100-KnockIn mouse spinal cord shows progressive TDP43 pathology associated with cholesterol biosynthesis suppression. Neurobiol. Dis. 152, 105289. https:\/\/doi.org\/10.1016\/j.nbd.2021.105289 (2021).","journal-title":"Neurobiol. Dis."},{"key":"12133_CR32","doi-asserted-by":"publisher","first-page":"6490","DOI":"10.1523\/JNEUROSCI.0630-12.2012","volume":"32","author":"A Mohamed","year":"2012","unstructured":"Mohamed, A., Saavedra, L., Di Pardo, A., Sipione, S. & PossedeChaves, E. Beta-amyloid inhibits protein prenylation and induces cholesterol sequestration by impairing SREBP-2 cleavage. J. Neurosci. 32, 6490\u20136500. https:\/\/doi.org\/10.1523\/JNEUROSCI.0630-12.2012 (2012).","journal-title":"J. Neurosci."},{"key":"12133_CR33","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nrneurol.2011.132","volume":"7","author":"JM Karasinska","year":"2011","unstructured":"Karasinska, J. M. & Hayden, M. R. Cholesterol metabolism in Huntington disease. Nat. Rev. Neurol. 7, 561\u2013572. https:\/\/doi.org\/10.1038\/nrneurol.2011.132 (2011).","journal-title":"Nat. Rev. Neurol."},{"key":"12133_CR34","first-page":"568","volume":"13","author":"LJ Martin","year":"2010","unstructured":"Martin, L. J. Olesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosis. IDrugs Investig. Drugs J. 13, 568\u2013580 (2010).","journal-title":"IDrugs Investig. Drugs J."},{"key":"12133_CR35","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/ene.12344","volume":"21","author":"T Lenglet","year":"2014","unstructured":"Lenglet, T. et al. A phase II\u2013III trial of olesoxime in subjects with amyotrophic lateral sclerosis. Eur. J. Neurol. 21, 529\u2013536. https:\/\/doi.org\/10.1111\/ene.12344 (2014).","journal-title":"Eur. J. Neurol."},{"key":"12133_CR36","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab186","author":"G Birolini","year":"2021","unstructured":"Birolini, G. et al. SREBP2 gene therapy targeting striatal astrocytes ameliorates Huntington\u2019s disease phenotypes. Brain https:\/\/doi.org\/10.1093\/brain\/awab186 (2021).","journal-title":"Brain"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12133-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12133-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12133-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T22:13:51Z","timestamp":1669328031000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12133-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,14]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["12133"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-12133-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,14]]},"assertion":[{"value":"20 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7988"}}